Table 2.

Circumstances of diagnosis of cervical cancer at advanced (group B) versus localized (group A) stage

	Group A N = 25	Group B N = 71	p-value
Routine examination	15/25 (60%)	6/65 (9.23%)	< 0.001
Cervical cytology screening	11/24 (45.82%)	11/68 (16.18%)	0.003
Colposcopy for the diagnosis	16/25 (64%)	24/57 (42.11%)	0.22
Vaginal bleeding	9/25 (36%)	58/68 (85.29%)	< 0.001
Post coital vaginal bleeding	2/25 (8%)	9/68 (13.24%)	0.39
Appearance of cervix			0.04
Normal appearance	5/24 (20.83%)	5/67 (7.46%)
Budding	2/24 (8.33%)	24/67 (35.82%)
Gross erosion, ulcer	13/24 (54.17%)	26/67 (38.81%)
Local induration	3/24 (12.50%)	8/67 (11.94%)
Necrosis	1/24 (4.17%)	4/67 (5.97%)
General symptoms	0/25 (0%)	21/67 (31.34%)	0.001

Percentages are the frequency within each group, denominators for available data within the group